MedTrace Logo

Use of Loteprednol for Contact Lens Intolerance and Dryness

NCT00817557 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2009-01-06

No results posted yet for this study

Summary

Study of the effects of Loteprednol on CL dryness

Conditions

  • Contact Lenses Dryness

Interventions

DRUG

Loteprednol

Anti-inflammatory

OTHER

Rewetter

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    collaborator INDUSTRY

  • Hom, Milton M., OD, FAAO

    lead INDIV

Principal Investigators

  • Milton M Hom, OD FAAO · Private Practice

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-06-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00817557 on ClinicalTrials.gov